SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001193125-17-313995
Filing Date
2017-10-19
Accepted
2017-10-19 16:39:56
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM F-3 d440555df3.htm F-3 391345
2 EX-5.1 d440555dex51.htm EX-5.1 19472
3 EX-23.1 d440555dex231.htm EX-23.1 2542
4 GRAPHIC g440555g38a88.jpg GRAPHIC 52606
5 GRAPHIC g440555g82h99.gif GRAPHIC 2486
6 GRAPHIC g440555g90m06.gif GRAPHIC 417
7 GRAPHIC g440555g95n51.jpg GRAPHIC 10566
  Complete submission text file 0001193125-17-313995.txt   505640
Mailing Address LEVEL 12, 95 PITT STREET SYDNEY, NEW SOUTH WALES C3 2000
Business Address LEVEL 12, 95 PITT STREET SYDNEY, NEW SOUTH WALES C3 2000 612 9276 1224
Prima BioMed Ltd (Filer) CIK: 0001506184 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-221021 | Film No.: 171145084
SIC: 2834 Pharmaceutical Preparations